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Evolution of a G protein-coupled receptor response
by mutations in regulatory network interactions
Raphae¨l B. Di Roberto1, Belinda Chang1, Ala Trusina2 & Sergio G. Peisajovich1
All cellular functions depend on the concerted action of multiple proteins organized in
complex networks. To understand how selection acts on protein networks, we used the yeast
mating receptor Ste2, a pheromone-activated G protein-coupled receptor, as a model system.
In Saccharomyces cerevisiae, Ste2 is a hub in a network of interactions controlling both signal
transduction and signal suppression. Through laboratory evolution, we obtained 21 mutant
receptors sensitive to the pheromone of a related yeast species and investigated the
molecular mechanisms behind this newfound sensitivity. While some mutants show
enhanced binding afﬁnity to the foreign pheromone, others only display weakened
interactions with the network’s negative regulators. Importantly, the latter changes have a
limited impact on overall pathway regulation, despite their considerable effect on sensitivity.
Our results demonstrate that a new receptor–ligand pair can evolve through network-altering
mutations independently of receptor–ligand binding, and suggest a potential role for such
mutations in disease.
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I
mportant cellular processes result from the concerted action of
multiple proteins organized in complex networks. Studies in
evolution have revealed how individual proteins can acquire
new functions due to changes in their binding speciﬁcity or
catalytic potential1–5. However, these characteristics alone often
cannot explain the evolution of complex cellular functions,
because network output does not solely depend on the function of
an individual protein, but rather on the integrated function of
multiple components with intricate regulatory relationships6.
Past work has found evidence of network ‘re-wiring’ in
evolution from large-scale data7–9, whereby proteins are
conserved across organisms but the interactions between them
differ, although the molecular basis of such re-wiring is not
always evident. Studies focusing on well-characterized signalling
systems in bacteria10, yeast11 and mammals12,13 have shed light
on how changes in protein interactions can alter regulatory
networks. Similarly, recent work has demonstrated that domain
shufﬂing can extensively re-wire a signalling network by
exchanging interaction motifs between proteins14–16, a process
that has been linked to the evolution of organism complexity17.
Though much progress has been made, it remains unclear how
selection acts on regulatory networks during the evolution of a
new function.
To examine this question, we followed in real time the initial
steps in the evolution of the response to a new ligand in the yeast
pheromone receptor Ste2, a G protein-coupled receptor (GPCR).
In Saccharomyces cerevisiae (hereafter abbreviated Scer) and in
related ascomycetes, the mating process involves the fusion of two
haploid cells to produce a diploid daughter18. In one mating type,
this process is triggered when the pheromone a-factor binds to its
cognate receptor Ste2. This GPCR acts as a network hub,
mediating both signal transduction and signal suppression
through interactions with multiple protein partners (Fig. 1a).
These interactions have been extensively studied and are
conserved from yeast to humans19–21. For signal transduction,
pheromone-bound Ste2 mediates the exchange of GDP for GTP
in a heterotrimeric G protein. This triggers a mitogen-activated
protein kinase (MAPK) cascade leading to the expression of
mating-related genes. In addition, Ste2 contributes to signal
suppression through its cytoplasmic domain. First, the receptor
brings Sst2, a regulator of G-protein signalling (RGS), in
proximity to its target, Gpa1a, to promote GTP hydrolysis
and shut down signalling22. Second, Ste2 is internalized as
homo-oligomers and degraded both constitutively and on
ligand binding, a process that involves sequential receptor
phosphorylation, ubiquitination and the recruitment of the
clathrin endocytic machinery23–26. Ste2’s central role in both
network activation and signal suppression, along with its
well-characterized and highly conserved regulatory interactions,
make it an ideal target to investigate the contribution of
network-altering mutations to the evolution of new function.
We hypothesized that the evolution of a new function in the
yeast mating pathway could occur through changes in the
signalling hub Ste2. To test this, we mimicked an evolutionary
scenario in which Scer cells were under selection pressure to
respond to a weak agonist, the pheromone of the related species
Kluyveromyces lactis (hereafter abbreviated Klac). To focus on the
receptor and its interactions, we introduced random mutations
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Figure 1 | The G protein-coupled receptor Ste2, a network hub in the yeast mating pathway, is used to study the contribution of network interactions
in the evolution of a new response. (a) Ste2 contributes to both signal transduction and signal suppression through a variety of physical interactions.
(b) Dose-response relationship of cells expressing GFP in response to mating pathway activation. Cells were treated with various concentrations of
pheromone and incubated for 3 h. GFP ﬂuorescence was measured by ﬂow cytometry. Wild-type Ste2 confers a weak, low-sensitivity response to Klac
a-factor, a foreign pheromone. Error bars represent the s.e.m. (c) Schematic view of our directed evolution method. A plasmid library of STE2 mutants
generated by error-prone PCR was transformed in ste2D yeast. Cells were treated with 5mM Klac a-factor and incubated for 3 h. Fluorescence-activated cell
sorting was used to select for highly-activating variants which were then plated. Individual colonies were screened to conﬁrm the desired phenotype and
sequenced.
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only in Ste2. We then used high-throughput selection to isolate
cells that activated the mating pathway in response to Klac
a-factor. We investigated the contribution of network-altering
mutations by performing a detailed phenotypic analysis on a
subset of selected variants.
Our analysis revealed two distinct evolutionary paths:
a ‘classical’ path involving improvements in binding afﬁnity for
the foreign agonist; and a ‘network-altering’ path, wherein the
interaction between the receptor and the RGS is no longer
conducive to signal suppression due to a partial loss of the
receptor’s cytoplasmic tail. Importantly, receptors truncations
have only a limited effect on pathway regulation, suggesting that
the partial loss of this interaction-rich region can be an acceptable
evolutionary strategy, an observation supported by the large
variability in cytoplasmic tail lengths found among Ste2
homologues. Altogether, these results point to a novel mechanism
of network evolution, and suggest a possible link between RGS
proteins and disease-causing GPCR mutations.
Results
Directed evolution of Ste2 yields diverse response proﬁles. To
characterize the mating response of Scer cells with different
pheromones, we used a strain in which the promoter of the gene
FUS1 drives the expression of green ﬂuorescent protein (GFP)27.
We found that wild-type Scer cells respond weakly but
consistently to Klac a-factor with a lower sensitivity (higher
EC50) and a lower maximum than the response to Scer a-factor
(Fig. 1b). We also tested the a-factor pheromone of two more
related species: Naumovozyma castellii (formerly Saccharomyces
castellii) and Candida glabrata (abbreviated Cgla). However, the
former elicited a response comparable to that of the native Scer
pheromone while the response to the latter was negligible (data
not shown). As we sought a weak, but measurable response, we
proceeded to use Klac a-factor for our directed evolution
experiment.
We used directed evolution to obtain variants of the
pheromone receptor Ste2 that conferred a strong response to
Klac a-factor (Fig. 1c). First, we transformed a ste2D yeast strain
with a plasmid-based library of STE2 mutants generated by
error-prone PCR. We then used ﬂuorescence-activated cell
sorting to select cells able to respond strongly to treatment with
5 mM Klac a-factor. After two iterative rounds of cell sorting
followed by a screening step to isolate individual non-constitutive
variants, we obtained 21 mutant receptors capable of responding
strongly to Klac a-factor.
Sequencing of the selected Ste2 variants revealed a diversity of
genotypes with one or more protein mutations (Supplementary
Table 1), and mutated sites spread throughout the entire receptor
(Supplementary Fig. 1A). The mutant receptors were labelled
according to their most severe protein mutation (S: substitution,
T: truncation, F: frameshift) and numbered. Many of the mutated
sites were recurrent within our set of selected variants, or had
been implicated in receptor function in past studies24,28–39.
We found that all selected receptors retained their ability to
respond strongly to Scer pheromone, with most also displaying
the ability to respond to Cgla a-factor (Supplementary Fig. 1B).
These two features, a robust native response and the facile
emergence of promiscuity in the function under selection, are
thought to underlie the evolution of new protein functions in
nature40–43.
To characterize Ste2 mutants in detail and uncover potential
changes in receptor–network interactions, we focused on a subset
of 10 variants with sites mutated more than once and/or mutated
sites known to affect Ste2 signalling such as V280 (ref. 35)
or C-terminal lysines28 (Table 1). We ﬁrst measured the
dose–response relationship of each variant with either Klac or
Scer a-factor to identify possible phenotypic clusters. As shown in
Fig. 2 (left column), we grouped mutants into four clusters based
on differences in their sensitivity (EC50), baseline response and
maximum response. Interestingly, the patterns uncovered with
Scer pheromone were not found with Klac a-factor, with the latter
yielding more diverse dose-response relationships (Fig. 2, right
column). This diversity was probably a consequence of our
selection regime, wherein the single concentration of foreign
pheromone used (5 mM) imposed no constraints on the
strength of the response at other concentrations, making
various sensitivities and Hill coefﬁcients permissible.
Binding afﬁnity does not explain all acquired sensitivity. Many
of the selected Ste2 variants harboured mutations in the extra-
cellular loops of the receptors or in regions that were previously
implicated in ligand binding36,44,45. To differentiate between
variants that had acquired a greater binding afﬁnity for the
foreign pheromone and those that had not, we measured
receptor–ligand afﬁnity in live cells using a ﬂuorescently
labelled pheromone and ﬂow cytometry. As the assay was done
with live cells, we were able to simultaneously measure the
amount of receptors at the cell surface for each variant (Bmax).
Cells were kept on ice during measurements to minimize the
effects of ligand-induced receptor internalization, ensuring that
Bmax values are ligand independent.
We found that all variants tested displayed a strong binding
afﬁnity to Scer a-factor (Fig. 3a). Conversely, we observed
important differences across variants when comparing Bmax
values and Klac a-factor afﬁnity (Fig. 3b). Half of the variants
assayed displayed a stronger afﬁnity for Klac a-factor than the
wild type (4 out of 10 when considering statistical signiﬁcance),
but had no increases in surface receptor expression. Of the
remaining variants, three were highly expressed at the surface
(two were signiﬁcant). Interestingly, four variants had dramatic
changes in the receptor’s cytoplasmic tail resulting from either a
premature stop codon or a frameshift mutation.
Among the mutant receptors showing a high binding afﬁnity
for Klac a-factor, variants S1, S2 and S4 showed an unchanged
response sensitivity to Scer a-factor, but different sensitivities to
Klac a-factor (Fig. 2). For these, the ligand-speciﬁc effects of their
mutations suggested that changes at their binding site speciﬁcally
contributed to their phenotype. However, the presence of
several low-afﬁnity variants led us to conclude that a stronger
receptor–ligand interaction was not the sole evolutionary path
Table 1 | Ste2 variants and their dose-response sensitivity to
either pheromone.
Name Protein mutations Scer EC50
(nM)
Klac EC50
(nM)
WT NA 8.74±2.2 726±240
S1 I82N, N216D, Y266F 4.36±0.42 19.1±6.3
S2 V280I 5.90±1.2 107±2.5
S3 S267C,V280D, K358R,T414M 1.73±0.096 6.24±1.4
S4 N216S 8.45±0.11 24.1±7.6
S5 S267R, T282S 3.30±0.19 86.6±28
S6 M54V, A62T, M69L, G115R 7.81±0.11 1500±620
T1 Y30H, K358* 0.375±0.14 80.4±12
T2 T78M, A336D, K337P, S338E,
S339*
0.909±0.20 100±8.9
T3 G237D, F312L, R350* 0.758±0.0049 84.7±20
F1 N25D, K202T, T309N, A397E,
Fs401
0.649±0.27 224±1.8
NA, not applicable; WT, wild type.
Asterisks designate a premature stop codon while ‘Fs’ designates a frameshift mutation.
Values represent the mean±s.e.m.
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favoured by our directed evolution experiment. For such variants,
we had to consider other possible mechanisms.
GPCR tail length variability is found in natural evolution. We
were surprised by the prominence of C-terminal tail truncations
among low-afﬁnity variants due to the role of this region in
numerous regulatory interactions and the apparent severity of
this type of mutation. In total, we isolated ﬁve variants with
premature stop codons with tail lengths of 39, 50, 58, 103 and 124
amino acids. This remarkable tolerance to truncations suggests
that this region does not adopt a well deﬁned structure46 and
this was conﬁrmed with FoldIndex47, a predictor of disordered
regions (Supplementary Fig. 2). To determine whether
cytoplasmic tail length variability is a natural trait of GPCRs,
we examined the distribution of tail lengths in fungal Ste2
homologues. Through PSI-BLAST and the transmembrane
domain predictor TMHMM48, we retrieved 225 fungal GPCR
and their cytoplasmic tail sequences. We found a wide
distribution of tail lengths, ranging from less than 15 amino
acids to about 240 amino acids, which encompassed those of our
selected Ste2 variants (Fig. 3c). This conﬁrmed that the truncated
receptors selected in our study resemble Ste2 homologues found
in nature and pointed to numerous truncation-elongation events
in the evolutionary history of GPCRs.
We hypothesized that the partial loss of the cytoplasmic tail
seen in some variants was a driving mutation behind Klac
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Figure 2 | Ste2 variants selected for their ability to confer a strong response to a foreign pheromone exhibit diverse response proﬁles. Dose-response
proﬁles of selected Ste2 variants using either the native or foreign pheromone. Variants were clustered according to the shape of their response to
Scer a-factor. Error bars represent the s.e.m..
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a-factor sensitivity. Notably, variants T1 and T2 contained a
premature stop codon in their C-terminal tail and only one other
mutation occurring outside of this region. We found that
removing the latter mutation, as well as the sequence downstream
of the stop codon to eliminate any possible read-through did not
affect the overall properties of the truncated receptors (now called
T1* and T2*; Supplementary Table 2), suggesting that their
phenotype could be attributed to the truncation. To determine
how tail truncations affected the function of the evolved
receptors, we subsequently focused on these mutants.
Partial tail truncations impair the Ste2–Sst2 interaction. The
receptor’s C-terminal tail has been linked to two aspects of
negative pathway regulation: receptor internalization (also called
receptor endocytosis) and Sst2 recruitment. We conﬁrmed
via receptor–GFP fusions that T1* and T2* were defective at
internalizing, both with and without pheromone (Supplementary
Fig. 3). We reasoned that this was the cause of their high Bmax
values due to the accumulation of receptors at the cell surface.
In principle, one might expect that higher surface receptor
expression would enable the sensing of lower pheromone
concentrations, resulting in a more sensitive response. However,
past studies have shown that defective endocytosis has only a
minor effect on sensitivity to Scer a-factor49 and this may only be
apparent during long-term exposure to pheromone50. Likewise,
impaired homo-oligomerization, a key feature of endocytosis,
does not appear to greatly affect signalling although this has not
been studied systematically51. Finally, the impact of receptor
overexpression is more controversial22,52–54.
To understand these effects, we constructed a mathematical
model of a simpliﬁed Ste2 system (Supplementary Fig. 4,
Supplementary Note 1). Our model conﬁrmed that impaired
receptor endocytosis results in the accumulation of receptors at
the cell surface, but this was not predicted to shift the sensitivity
of the response. Instead, our model predicted that the EC50 could
be altered by unequal changes in the basal and induced rates of
receptor internalization. This result was also observed in an
analogous model focusing on the epidermal growth factor
receptor55. However, based on simulations with many
experimentally derived parameter values, we found that Ste2
mutants solely defective in endocytosis would only show modest
effects on sensitivity.
Our mathematical model led us to consider the receptor’s
interaction with the RGS Sst2 as the main source of the sensitivity
shift. Ste2 is thought to bring Sst2 in proximity of its membrane-
anchored target, the GTPase subunit of the heterotrimeric G
protein, through a physical interaction that enables efﬁcient
pathway deactivation22. This interaction is abolished in the RGS
mutant Sst2Q304N, and this confers a greater sensitivity to the
native pheromone56.
To experimentally test whether a greater sensitivity to Klac
a-factor could result from receptor overexpression, impaired
endocytosis and/or Sst2 recruitment, we measured Klac a-factor
sensitivity under each scenario. First, we designed a gene
construct in which wild-type receptor expression was driven by
the strong promoter of the gene ADH1 (pADH1). The Bmax value
for pADH1-expressed Ste2 was 6.05±0.65-fold higher than that
of Ste2 expressed from its endogenous promoter. Second, we
obtained a Ste2 variant in which all C-terminal lysines involved in
endocytosis were substituted to arginine, dubbed 7KtoR28. This
variant is defective in endocytosis but not in Sst2 recruitment22.
Third, we co-expressed the wild-type receptor with Sst2Q304N.
The resulting dose-response curves and their EC50 values are
shown in Fig. 4a,b, respectively. Strikingly, we found that among
the three scenarios, only Sst2Q304N conferred improved sensitivity
to Klac a-factor. Since we allow GFP expression to proceed for 3 h
before making measurements, we considered the possibility
that signalling under conditions of high receptor expression or
low endocytosis was quashed by Sst2 over time. Therefore,
we measured MAPK phosphorylation 30min after Klac a-factor
treatment by western blotting. Once again, only Sst2Q304N
showed high MAPK phosphorylation levels (Supplementary
Fig. 5).
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Figure 3 | Ligand binding afﬁnity and surface receptor expression
suggest independent mechanisms behind sensitivity to Klac a-factor.
(a) Binding constants of Ste2 variants for NBD-labelled Scer pheromone.
Values were obtained from a saturation assay in live cells using ﬂow
cytometry. None of the Ste2 variants displayed a signiﬁcant difference to
wild-type (Dunnett’s Multiple Comparison Test). Error bars represent the
s.e.m. (b) Binding constants for Klac a-factor (left) plotted alongside
surface receptor expression (right). Binding constants were obtained from a
competition assay using a range of concentrations of Klac a-factor and a
constant concentration of 20 nM NBD-labelled Scer a-factor. Surface
expression was measured from a saturation assay. A subset of Ste2 variants
exhibit high binding afﬁnity for the foreign pheromone, while another
subset displays high surface receptor expression. Asterisks indicate
statistically signiﬁcant differences to wild-type (Po0.05, Dunnett’s
Multiple Comparison Test). Error bars represent the s.e.m. (c) Fungal Ste2
homologues were obtained from PSI-BLAST and transmembrane domain
topologies were predicted by TMHMM48. The lengths of C-terminal tails
were extrapolated from the predicted topologies and plotted as a frequency
distribution. This wide distribution encompasses the lengths of our Ste2 tail
truncation mutants (indicated by labels above the bars).
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We proceeded to determine whether our truncated receptors
were more sensitive to Klac a-factor due to an altered interaction
with Sst2. We reasoned that if a partial tail truncation weakened
the receptor’s interaction with Sst2, its effect would be equivalent
to that caused by the Q304N mutation in Sst2 and, in
consequences, the two mutations combined should not display
an additive phenotype. We co-expressed truncated receptors or
high-afﬁnity variants with Sst2Q304N and measured cells’
sensitivity to Klac pheromone. We found that the sensitivity
conferred by Sst2Q304N was not improved when receptor
truncations were co-expressed (Fig. 4c). Conversely, the high
binding afﬁnity variants S2 and S4 produced an even more
sensitive response when co-expressed with Sst2Q304N.
While these results pointed to an altered interaction between
truncated receptors and Sst2, we sought to determine if the
interaction was in fact physically weaker rather than
simply improper and to what extent. For this, we used
bimolecular ﬂuorescence complementation with Venus ﬂuores-
cent protein57,58. In this assay, Ste2 and Sst2 are fused to the
C- and N-terminal halves of Venus, respectively. On physical
interaction, Venus is reconstituted and its ﬂuorescence can be
detected by ﬂow cytometry and normalized to protein expression
levels (Supplementary Table 3). The Venus ﬂuorescence for
different construct combinations is presented in Fig. 4d. We
found that wild-type Ste2 and Sst2 produced signiﬁcantly more
ﬂuorescence per Ste2 molecule than wild-type Ste2 and
Sst2Q304N, conﬁrming the reduced physical interaction found
by Ballon et al22. Remarkably, the truncated receptors T1 and T2
also caused lower Venus ﬂuorescence than wild-type, though
higher than Sst2Q304N. On the other hand, the two binding
mutants S2 and S4 showed similar Venus ﬂuorescence compared
with wild-type. Together, these results suggest that the sensitivity
of partial tail truncations to the foreign pheromone can be
attributed to an impaired interaction with Sst2.
Partial receptor truncations impair Sst2 activity. We further
investigated the effects of receptor truncations on Sst2 activity
and pathway regulation. In the absence of a Ste2–Sst2 interaction,
either through a point mutation in the RGS or by truncating the
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Figure 4 | A decreased interaction with Sst2 explains the sensitivity shift of partially truncated receptors. (a) Dose-response relationship of various
Ste2 or Sst2 constructs with Klac a-factor. Only the variant Sst2Q304N, which does not interact with the receptor, enables a stronger response to the foreign
pheromone. (b) Mating response sensitivity for the Ste2 or Sst2 constructs assayed in a. EC50 values were derived from duplicate dose-response
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truncated receptors. (d) Bimolecular ﬂuorescence complementation of Venus fragments fused to Ste2 and Sst2. Venus ﬂuorescence was measured by ﬂow
cytometry in duplicate experiments and normalized by the Bmax values of the Ste2-C-Venus variants. Venus ﬂuorescence was lower when cells expressed
Sst2Q304N or truncated Ste2, suggesting that these mutations impair the interaction between the receptor and its RGS. Asterisks indicate statistically
signiﬁcant differences to wild-type (Po0.05, Dunnett’s multiple comparison test). All error bars represent the s.e.m.
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entire C-terminal tail of the receptor, Sst2 is deﬁcient in promoting
signal downregulation and recovery from pheromone-induced
cell cycle arrest22. However, it was unclear if partial receptor tail
truncations, such as those found in T1* and T2*, would have
similar consequences. Past work suggests that the receptor’s third
intracellular loop may also contribute to Sst2 function33, possibly
as an additional contact point which could offset the effects of
partial truncations.
An important feature of normal Sst2 function is fast pathway
deactivation as reﬂected by the dephosphorylation of Fus3, the
pathway’s MAPK56. Since pathway activation causes cell cycle
arrest, a rapid shut-off ensures that cells without a compatible
mate are able to resume growth. We reasoned that if partial tail
truncations affected Sst2 function, the dynamics of MAPK
dephosphorylation, as well as the rates of growth recovery,
would reveal this.
We measured the levels of phosphorylated Fus3 following
pheromone wash-off, as was previously done by Dixit et al56.
Importantly, as we sought to determine whether binding afﬁnity
inﬂuenced this process, we performed this assay under mild
washing conditions. As previously reported, we conﬁrmed that
levels of phosphorylated Fus3 declined rapidly in wild-type cells
(Supplementary Fig. 6A), while the expression of Sst2Q304N
resulted in slower pathway deactivation (Supplementary
Fig. 6B). We also observed that rapid pathway deactivation was
preserved for the high-afﬁnity variants S2 and S4, whether Scer or
Klac pheromones were used to activate the pathway (Fig. 5a,b). In
contrast, pathway regulation was more complex for the truncated
receptors T1* and T2*. When treated with Scer a-factor, these
variants exhibited slow Fus3 dephosphorylation (Fig. 5c) as
predicted, further indicating that their partial tail truncations
impaired normal Sst2 function. However, this effect was not
observed when Klac a-factor was used to activate the pathway
(Fig. 5d). Remarkably, cells expressing Sst2Q304N and treated with
Klac a-factor showed a similar result (Supplementary Fig. 6C,D).
The different rates of pathway deactivation could not be
explained by the initial levels of phosphorylated Fus3, as these
were all comparable for each pheromone (Supplementary
Fig. 6E,F), which deactivated rapidly in all cases. Instead, these
results pointed to a pheromone-speciﬁc effect, whereby a partial
Sst2 function could still downregulate Fus3 phosphorylation
provided that the receptor was activated by a weak ligand. We
reasoned that if a truncated receptor were activated more potently
by Klac pheromone, its deactivation would be slower. To test this,
we generated hybrid mutants by truncating the high binding
afﬁnity mutants S2 and S4 to the same extent as T1*, which we
called S2–T1 and S4–T1. As expected, these hybrid mutants
displayed slow Fus3 dephosphorylation even when Klac
pheromone was used, although this effect was less pronounced
than with Scer pheromone (Fig. 5e,f). Remarkably, these results
were mirrored in growth assays where cell density was measured
for 7 h following pheromone treatment and wash-off (Fig. 5g,h).
Rapid dephosphorylation correlated with rapid growth, while
slow dephosphorylation matched slow growth.
Taken together, these experiments suggest that Sst2 plays two
distinct roles. First, Sst2 creates a threshold of receptor activation
needed to activate the pathway, with partial Ste2 truncations
enabling a response to a weak agonist by lowering this threshold.
Second, Sst2 also contributes to pathway deactivation and this
depends on both its interaction with the receptor and the afﬁnity
of the ligand (Fig. 6). Importantly, neither an altered Ste2–Sst2
interaction nor a high-afﬁnity ligand alone can disrupt pathway
deactivation. In the case of T1* and T2* treated with Klac
a-factor, the interaction with Sst2 is impaired, thereby lowering
the activation threshold that it provides, but with no con-
sequences on deactivation, Sst2’s second function. In this way,
truncated receptors confer a strong response to Klac pheromone
while preserving normal pathway deactivation and growth
recovery.
Mutants can mediate the formation of mating projections. An
additional function of Ste2’s C-terminal tail consists in regulating
the proper formation of mating projections, also known as
shmoos. Mating projections are a critical step in the fusion of
haploid yeast cells, the end goal of mating pathway activation18.
While full C-terminal truncations strongly affect shmoo
orientation toward potential mates, the impact of partial
truncations is less severe and they permit mating59,60. Recent
work demonstrated that Sst2’s RGS activity, but not its
interaction with Ste2, is required for proper mating
orientation61. To conﬁrm this, we tested the ability of our
truncated receptors to enable the formation of shmoos. Like
their high-afﬁnity counterparts, truncation mutants enabled the
formation of typical mating projections based on morphology
and frequency when treated with either pheromone
(Supplementary Fig. 7). In contrast, only a few cells expressing
wild-type Ste2 could shmoo when treated with Klac a-factor, and
the shape of their mating projections was atypical. Together with
GFP expression and MAPK phosphorylation, this data further
conﬁrms that mutant receptors confer a strong and biologically
meaningful response to a foreign pheromone.
Discussion
In this study, we investigated the role that mutations in a network
hub can have in the evolution of a protein network. Our ﬁndings
demonstrate that a GPCR can evolve the ability to respond to a
weak agonist through at least two distinct mechanisms. The ﬁrst
is classical, and consists of an altered interaction between the
receptor and the ligand reﬂected by an enhanced binding afﬁnity.
The second, which sheds light on an alternate evolutionary path,
involves a change in the relationship between the receptor and its
regulatory network. Speciﬁcally, we isolated multiple mutant Ste2
receptors with a truncated cytoplasmic tail, a region involved in
protein–protein interactions. These truncated receptors exhibited
various changes compared with wild-type Ste2, such as a higher
surface expression and defective endocytosis, but their sensitivity
to Klac a-factor was attributable to an impaired interaction with
Sst2, a signal suppressor of G protein activity. Strikingly, these
changes had a minimal impact on key aspects of pathway
regulation. Our results thus demonstrate that it is possible to
evolve a new receptor–ligand response by altering regulatory
network interactions rather than the receptor’s binding site.
Furthermore, the prominence of truncated receptors in our
selection, as well as the extensive cytoplasmic tail length
variability that we observed in natural Ste2 homologues, suggest
that evolutionary events that shorten or extend the cytoplasmic
tail are rather common and may contribute to adaptive functional
changes.
In a pioneering study performed over two decades ago,
Lorraine Marsh used laboratory evolution to obtain Ste2 variants
that could confer a mating response to the pheromone
of Saccharomyces kluyveri31. In this way, she found various
mutations affecting the receptor’s ability to discriminate between
the two ligands. However, due to a limited understanding of Ste2
signalling at the time, it was not possible to conclude on the
precise molecular mechanisms behind the new phenotype. In the
decades that followed, many more studies used mutagenesis
and selection to characterize Ste2, often by focusing on a single
region of the receptor and its hypothesized function. In this
way, different Ste2 variants revealed the amino acid residues
involved in pheromone binding32,44, signal transduction32,37,38,
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12344 ARTICLE
NATURE COMMUNICATIONS | 7:12344 | DOI: 10.1038/ncomms12344 | www.nature.com/naturecommunications 7
internalization23–25, oligomerization30,62 and signal
regulation22,29,33,62. While these studies led to a greater
understanding of the mechanisms behind the many facets of
Ste2 signalling, their combined role in the evolution of new
function remained unclear. Our work addresses this gap by
shedding light on the molecular mechanisms through which a
GPCR network can be linked to a foreign ligand.
As expected, our selection yielded several Ste2 variants with
mutations affecting the receptor’s binding site as revealed by
their signiﬁcantly enhanced binding afﬁnity to Klac a-factor.
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Figure 5 | MAPK phosphorylation dynamics and growth curves reveal the role of the receptor-RGS interaction in controlling both mating pathway
activation and deactivation. (a–f) Levels of phosphorylated Fus3 after pheromone wash-off for different Ste2 variants. Following mating pathway activation
with 3mM pheromone cells, were washed in pheromone-free medium, incubated for the indicated time and lysed. Lysates were used for Western
Blotting. Phosphorylated Fus3 levels were normalized to PGK levels and plotted. Green bar graphs indicate Scer a-factor, red indicated Klac a-factor.
(g–h) Growth curves of cells expressing different Ste2 or Sst2 variants. Following mating pathway activation with 3mM pheromone, cells were washed in
pheromone-free medium, incubated for the indicated time and culture density was measured by ﬂow cytometry. Values were normalized to the initial cell
concentration to yield a growth ratio. All error bars represent the s.e.m.
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Strikingly, all ﬁve high-afﬁnity variants share the same three
mutated sites: N216, V280 and S267. Mutations at the ﬁrst two
sites were previously shown to enable a pathway response to a
weak agonist as well as an antagonist34,35. Both sites were also
involved in suppressing a loss-of-function mutation at a known
pheromone-binding residue, Y266 (ref. 34). Although S267 was
not previously linked to pheromone binding, it is adjacent to
Y266 and thus may also contribute to binding. The apparent
broad speciﬁcity that arises when these residues are mutated,
which we further conﬁrmed with Klac and Cgla pheromones,
initially suggested that such residues were ‘gatekeepers’, ensuring
the speciﬁcity of the Ste2-a-factor interaction. However, our
results show that wild-type Ste2 binding is inherently
promiscuous. Instead, the RGS Sst2 is required to impose a
signalling threshold that is more stringent than binding
speciﬁcity, allowing cells to discriminate between strong or
weak ligands. Moreover, this threshold depends on a strong
interaction between Sst2 and the receptor, as Sst2’s presence alone
is also insufﬁcient to lock away the promiscuous potential of Ste2.
Despite the role of Ste2’s cytoplasmic tail in signalling
regulation, our data support the view that partially truncated
receptors retain key aspects of pathway regulation. First, these
variants did not result in constitutive signalling, indicating that
overall pathway responsiveness was preserved. Second, the
frequency and the morphology of mating projections in cells
expressing truncated receptors were undistinguishable from those
of wild-type cells, in agreement with a recent study that found
that truncated variants can mediate mating60. Third, pathway
deactivation proceeded normally in truncation mutants, provided
that the receptor’s interaction with the pheromone was weak.
When cells expressed receptors combining a truncation with a
binding afﬁnity mutation, Fus3 dephosphorylation was slow with
either pheromone. This suggests an interesting paradigm: if rapid
pathway deactivation is to be preserved, then receptors can
evolve either a stronger interaction with the ligand or a weaker
interaction with Sst2, but not both. Since pathway activation
causes cell cycle arrest, hybrid mutants may be disadvantaged
unless they can mate efﬁciently, leading to additional selection
pressure.
To conclude, our work highlights the prominent role of a
receptor–network interaction in the evolution of a new ligand
response. This scenario is of particular relevance in S. cerevisiae
where interspecies mating has been a major evolutionary driver63,
but its signiﬁcance can be extended to other GPCR networks due
to the underlying conservation that exists in this large family64,65.
Through partial C-terminal truncations, the yeast GPCR Ste2 can
acquire foreign pheromone sensitivity at little cost to signalling
regulation. This has interesting implications in the study of GPCR
evolution, where the highly variable length of the cytoplasmic tail
has not been thoroughly examined. Our work suggests that this
variability may not be random, but could instead be linked to
network re-wiring events. Furthermore, the demonstrated
importance of the RGS–tail interaction on response sensitivity
and ligand discrimination may be relevant in GPCR-linked
diseases. Alternative splice variants of GPCRs leading to
truncated receptors are well documented, but little is known
about their consequences beyond altered receptor trafﬁcking66–68.
If such splice variants are unable to interact with regulatory
factors, particularly RGS proteins, hypersensitivity and a lack of
ligand discrimination may play a role in their phenotype.
Methods
Mating pathway activation assays. Cells from three independent colonies were
treated with one or a series of concentrations of pheromone and placed in a 30 C
shaking incubator. After 3 h, protein synthesis was inhibited by treating cells with
10 mgml 1 cycloheximide. The intensity of the ﬂuorescence in the 525/50 nm
range was measured by analytical ﬂow cytometry with a MACSQuant VYB
(Miltenyi Biotec) with a 588 nm laser. Cells without receptors were used to subtract
basal cell ﬂuorescence from other samples to reveal the net GFP ﬂuorescence.
For dose-response assays, the data were ﬁtted with the ‘log(agonist) versus
response—Variable slope (four parameters)’ model in Prism (GraphPad). All
experiments included a wild-type Ste2 control. The ﬂuorescence intensity was
normalized to the maximum intensity of the wild-type control and multiplied
by 100. EC50 values represent the mean of two experiments normalized to the
wild-type value of each experiment.
Mutagenesis and selection. For mutagenesis, the full-length wild-type STE2 open
reading frame (ORF) was ampliﬁed from pRS-STE2 by error-prone PCR using the
GeneMorph II kit (Agilent). PCR conditions (500 ng of template DNA, 20 cycles)
were selected to yield a mean mutation rate of 4.0 DNA mutations per ORF. The
resulting amplimers were ligated in pRS-pSTE2 and ampliﬁed in E. coli DH5a to
generate a plasmid library of B50,000 Ste2 mutants. The library was transformed
in the yeast strain RB001, yielding 20,000 colonies. For selection, yeast cells were
treated with 5 mM Klac and incubated for 3 h in a 30 C shaker. Cell sorting was
done in a FACSAria (BD) while gating for high GFP ﬂuorescence. In the ﬁrst
round, 19,000 events were sorted. In the second round, which was done using the
cells recovered from the ﬁrst round, 11,000 events were sorted. A total of 282
colonies recovered from both rounds were screened for their ability to activate the
mating pathway better than wild type. Mutant STE2 genes were extracted from the
most promising colonies, transformed in naive cells to conﬁrm that they conferred
the phenotype, and sequenced.
Pheromone-binding assays. To measure binding afﬁnities and binding site levels,
we used the NBD-labelled pheromone binding assay69. Cells from two independent
colonies were treated with either varying concentrations of NBD-labelled Scer
(saturation binding assays) or varying concentrations of Klac pheromone mixed
with 20mM NBD-Scer (competition-binding assays) and left on ice for 10min with
occasional mixing. Samples were processed by ﬂow cytometry. For saturation
binding, the data were ﬁtted to the ‘One site—Total and nonspeciﬁc binding’ model
in Prism (GraphPad), and cells without receptors were used to account for
nonspeciﬁc binding. This model uses the equation Y¼Bmax[L]/(Kdþ [L])þN[L]
þBackground, where Y is the mean ﬂuorescence, [L] is the concentration of
labelled ligand and N is a proportionality constant for nonspeciﬁc binding.
For competition binding, the background-subtracted data were ﬁtted to the
‘One site—Fit Ki’ model with the appropriate constraints. This model uses the
equation Ki¼ IC50/(1þ [L]/KD). All experiments included a wild-type Ste2 control.
KD, Bmax and Ki values represent the mean of two experiments normalized to the
wild-type values of each experiment.
Low sensitivity,
fast deactivation
High sensitivity,
fast deactivation
High sensitivity,
slow deactivation
Hybrid mutants
Binding mutants
Truncation mutants
Wild type
Weaker
receptor–RGS
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Stronger
ligand–receptor
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K
Figure 6 | Pathway regulation depends on both ligand-receptor binding
and a receptor-RGS interaction. Schematic map of the Ste2 evolutionary
landscape. A stronger ligand-receptor interaction or a weaker receptor-RGS
interaction can each promote mating response sensitivity to Klac
pheromone, while a combination of the two is accompanied with slower
pathway deactivation.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12344 ARTICLE
NATURE COMMUNICATIONS | 7:12344 | DOI: 10.1038/ncomms12344 | www.nature.com/naturecommunications 9
Predicting the lengths of C-terminal tails in Ste2 homologues. To identify the
predicted disordered region, the amino acid sequence of Scer Ste2 was queried in
FoldIndex47. PSI-BLAST for three iterations and with default parameters70.
We restricted the search to matches of fungal origin, excluded Scer matches
and discarded partial sequences. We submitted the resulting dataset to the
transmembrane domain predictors TMHMM48 and extracted the predicted
topology of sequences with seven transmembrane domains. As TMHMM also
predicts the orientation of the helices, we discarded sequences for which the
C-terminal tail was extracellular. From the resulting topologies, we measured the
length of the cytosolic tail by deﬁning its N-terminal boundary as the last amino
acid of the seventh transmembrane domain, and its C-terminal boundary as the
stop codon. The frequency distribution of the resulting amino acid lengths was
plotted in Prism (Graphpad).
Bimolecular ﬂuorescence complementation. To measure the relative strength
of the physical interaction between Ste2 variants and Sst2 variants, we used
bimolecular ﬂuorescence complementation with Venus ﬂuorescent protein57,58.
N- and C-terminal Venus fragments were generated by dividing the protein at
amino acids 172–173. C-Venus was fused to Ste2 variants and N-Venus to Sst2
variants. Venus ﬂuorescence was measured by ﬂow cytometry as for GFP and
normalized to the Bmax of each receptor construct to account for receptor
expression levels. Bmax values were obtained with NBD-Scer as described above.
Western blotting of MAPK deactivation. Activation and deactivation of the
mating pathway was performed as described in ref. 56. Brieﬂy, cells were treated
with 3 mM pheromone and incubated in a 30 C shaker for 30min. The pheromone
was washed off with fresh growth medium and cell aliquots were taken
immediately after wash-off or following 10 and 20min incubations. Cell lysates
were resolved in a 10% SDS–PAGE gel and transferred to a PVDF membrane using
a BioRad Trans-Blot Turbo. Membranes were blocked overnight with Licor
Odyssey TBS-formulated blocking buffer. Blotting of Fus3-P was done with a
primary anti-p44/42 MAPK antibody (Cell Signaling Technology, #4370) diluted
by 1:2,000, followed by the secondary antibody IRDYE 800 (Licor, #926–32211).
Blotting of total Fus3 was done with a primary anti-Fus3 antibody (Santa Cruz
Biotechnology, #sc6773) diluted by 1:5,000, followed by the secondary antibody
IRDYE 800 (Licor, #926–32214). Blotting of the loading control phosphoglycerate
kinase (PGK) was done with a primary anti-PGK antibody (Invitrogen, #459250)
diluted by 1:5,000, followed by the secondary antibody IRDYE 680LT (Licor,
#926–68020). All secondary antibodies were diluted by 1:10,000. Bands were
visualized with a Licor Odyssey CLx infrared imaging system (Licor). Band
intensity was extracted with Image Studio Lite (Licor). The intensities of Fus3-P
bands were normalized to that of the PGK loading control. The experiment was
performed in duplicates.
Cell growth recovery assay. To measure recovery from cell cycle arrest, cells were
ﬁrst treated with 500 nM pheromone and incubated in a 30 C shaker for 30min.
The pheromone was then washed off with fresh growth medium. Culture aliquots
were taken immediately after wash-off (time zero) and subsequently every hour for
7 h. Aliquots were used to measure culture density by ﬂow cytometry. Culture
densities were normalized to time zero to obtain growth factors.
Data availability. The data that support the ﬁndings of this study are available
from the corresponding author on request. In addition, the uncropped versions of
the western blots featured in this article are available in Supplementary Figs 8–10.
References
1. Soskine, M. & Tawﬁk, D. S. Mutational effects and the evolution of new protein
functions. Nat. Rev. Genet. 11, 572–582 (2010).
2. Tracewell, C. A. & Arnold, F. H. Directed enzyme evolution: climbing ﬁtness
peaks one amino acid at a time. Curr. Opin. Chem. Biol. 13, 3–9 (2009).
3. Liang, J., Kim, J. R., Boock, J. T., Mansell, T. J. & Ostermeier, M. Ligand binding
and allostery can emerge simultaneously. Protein Sci. 16, 929–937 (2007).
4. Brown, S. D. & Babbitt, P. C. New insights about enzyme evolution from
large scale studies of sequence and structure relationships. J. Biol. Chem. 289,
30221–30228 (2014).
5. Dean, A. M. & Thornton, J. W. Mechanistic approaches to the study of
evolution: the functional synthesis. Nat. Rev. Genet. 8, 675–688 (2007).
6. Yu, R. C. et al. Negative feedback that improves information transmission in
yeast signalling. Nature 456, 755–761 (2008).
7. Yamada, T. & Bork, P. Evolution of biomolecular networks—lessons from
metabolic and protein interactions. Nat. Rev. Mol. Cell Biol. 10, 791–803
(2009).
8. Roguev, A. et al. Conservation and rewiring of functional modules revealed by
an epistasis map in ﬁssion yeast. Science 322, 405–410 (2008).
9. Ryan, C. J. et al. Hierarchical modularity and the evolution of genetic
interactomes across species. Mol. Cell 46, 691–704 (2012).
10. Capra, E. J. & Laub, M. T. Evolution of two-component signal transduction
systems. Annu. Rev. Microbiol. 66, 325–347 (2012).
11. Zarrinpar, A., Park, S. H. & Lim, W. A. Optimization of speciﬁcity in a cellular
protein interaction network by negative selection. Nature 426, 676–680 (2003).
12. Buljan, M. et al. Tissue-speciﬁc splicing of disordered segments that embed
binding motifs rewires protein interaction networks. Mol. Cell 46, 871–883
(2012).
13. Lynch, V. J., May, G. & Wagner, G. P. Regulatory evolution through divergence
of a phosphoswitch in the transcription factor CEBPB. Nature 480, 383–U139
(2011).
14. Peisajovich, S. G., Garbarino, J. E., Wei, P. & Lim, W. A. Rapid diversiﬁcation
of cell signaling phenotypes by modular domain recombination. Science 328,
368–372 (2010).
15. Lai, A., Sato, P. M. & Peisajovich, S. G. Evolution of synthetic signaling scaffolds
by recombination of modular protein domains. ACS Synth. Biol. 4, 714–722
(2015).
16. Sato, P. M., Yoganathan, K., Jung, J. H. & Peisajovich, S. G. The robustness of a
signaling complex to domain rearrangements facilitates network evolution.
PLoS Biol. 12, e1002012 (2014).
17. Di Roberto, R. B. & Peisajovich, S. G. The role of domain shufﬂing in the
evolution of signaling networks. J. Exp. Zool. B Mol. Dev. Evol. 322, 65–72
(2014).
18. Bardwell, L. A walk-through of the yeast mating pheromone response pathway.
Peptides 26, 339–350 (2005).
19. Widmann, C., Gibson, S., Jarpe, M. B. & Johnson, G. L. Mitogen-activated
protein kinase: conservation of a three-kinase module from yeast to human.
Physiol. Rev. 79, 143–180 (1999).
20. Hepler, J. R. Emerging roles for RGS proteins in cell signalling. Trends
Pharmacol. Sci. 20, 376–382 (1999).
21. Hislop, J. N. & von Zastrow, M. Role of ubiquitination in endocytic trafﬁcking
of G-protein-coupled receptors. Trafﬁc 12, 137–148 (2011).
22. Ballon, D. R., Flanary, P. L., Gladue, D. P., Konopka, J. B., Dohlman, H. G. &
Thorner, J. DEP-domain-mediated regulation of GPCR signaling responses.
Cell 126, 1079–1093 (2006).
23. Hicke, L., Zanolari, B. & Riezman, H. Cytoplasmic tail phosphorylation of the
alpha-factor receptor is required for its ubiquitination and internalization.
J. Cell Biol. 141, 349–358 (1998).
24. Howard, J. P., Hutton, J. L., Olson, J. M. & Payne, G. S. Sla1p serves as the
targeting signal recognition factor for NPFX(1,2)D-mediated endocytosis.
J. Cell Biol. 157, 315–326 (2002).
25. Tan, P. K., Davis, N. G., Sprague, G. F. & Payne, G. S. Clathrin facilitates the
internalization of seven transmembrane segment receptors for mating
pheromones in yeast. J. Cell Biol. 123, 1707–1716 (1993).
26. Yesilaltay, A. & Jenness, D. D. Homo-oligomeric complexes of the yeast
alpha-factor pheromone receptor are functional units of endocytosis. Mol. Biol.
Cell 11, 2873–2884 (2000).
27. Bashor, C. J., Helman, N. C., Yan, S. D. & Lim, W. A. Using engineered scaffold
interactions to reshape MAP kinase pathway signaling dynamics. Science 319,
1539–1543 (2008).
28. Terrell, J., Shih, S., Dunn, R. & Hicke, L. A function for monoubiquitination in
the internalization of a G protein-coupled receptor. Mol. Cell 1, 193–202 (1998).
29. Weiner, J. L., Guttierezsteil, C. & Blumer, K. J. Disruption of receptor-G protein
coupling in yeast promotes the function of an Sst2-dependent adaptation
pathway. J. Biol. Chem. 268, 8070–8077 (1993).
30. Uddin, M. S., Kim, H., Deyo, A., Naider, F. & Becker, J. M. Identiﬁcation of
residues involved in homodimer formation located within a beta-strand region
of the N-terminus of a Yeast G protein-coupled receptor. J. Recept. Sig. Transd.
32, 65–75 (2012).
31. Marsh, L. Substitutions in the hydrophobic core of the alpha-factor receptor of
saccharomyces-cerevisiae permit response to saccharomyces-kluyveri alpha-
factor and to antagonist. Mol. Cell. Biol. 12, 3959–3966 (1992).
32. Lin, J. C., Parrish, W., Eilers, M., Smith, S. O. & Konopka, J. B. Aromatic
residues at the extracellular ends of transmembrane domains 5 and 6 promote
ligand activation of the G protein-coupled alpha-factor receptor. Biochemistry
42, 293–301 (2003).
33. Stefan, C. J. & Blumer, K. J. The third cytoplasmic loop of a yeast
G-protein-coupled receptor controls pathway activation, ligand discrimination,
and receptor internalization. Mol. Cell. Biol. 14, 3339–3349 (1994).
34. Abel, M. G., Lee, B. K., Naider, F. & Becker, J. M. Mutations affecting ligand
speciﬁcity of the G-protein-coupled receptor for the Saccharomyces cerevisiae
tridecapeptide pheromone. Biochem. Biophys. Acta 1448, 12–26 (1998).
35. Lin, J. C., Duell, K., Saracino, M. & Konopka, J. B. Identiﬁcation of residues that
contribute to receptor activation through the analysis of compensatory
mutations in the G protein-coupled alpha-factor receptor. Biochemistry 44,
1278–1287 (2005).
36. Lee, B. K., Khare, S., Naider, F. & Becker, J. M. Identiﬁcation of residues of
the Saccharomyces cerevisiae G protein-coupled receptor contributing to
alpha-factor pheromone binding. J. Biol. Chem. 276, 37950–37961 (2001).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12344
10 NATURE COMMUNICATIONS | 7:12344 |DOI: 10.1038/ncomms12344 | www.nature.com/naturecommunications
37. Parrish, W., Eilers, M., Ying, W. W. & Konopka, J. B. The cytoplasmic end of
transmembrane domain 3 regulates the activity of the Saccharomyces cerevisiae
G-protein-coupled alpha-factor receptor. Genetics 160, 429–443 (2002).
38. Sommers, C. M., Martin, N. P., Akal-Strader, A., Becker, J. M., Naider, F. &
Dumont, M. E. A limited spectrum of mutations causes constitutive activation
of the yeast alpha-factor receptor. Biochemistry 39, 6898–6909 (2000).
39. Sommers, C. M. & Dumont, M. E. Genetic interactions among the
transmembrane segments of the G protein coupled receptor encoded by the
yeast STE2 gene. J. Mol. Biol. 266, 559–575 (1997).
40. Aharoni, A., Gaidukov, L., Khersonsky, O., Gould, S. M., Roodveldt, C. &
Tawﬁk, D. S. The ’evolvability’ of promiscuous protein functions. Nat. Genet.
37, 73–76 (2005).
41. Matsumura, I. & Ellington, A. D. In vitro evolution of beta-glucuronidase into a
beta-galactosidase proceeds through non-speciﬁc intermediates. J. Mol. Biol.
305, 331–339 (2001).
42. Khersonsky, O., Roodveldt, C. & Tawﬁk, D. S. Enzyme promiscuity:
evolutionary and mechanistic aspects. Curr. Opin. Chem. Biol. 10, 498–508
(2006).
43. Carroll, S. M., Bridgham, J. T. & Thornton, J. W. Evolution of hormone
signaling in elasmobranchs by exploitation of promiscuous receptors. Mol. Biol.
Evol. 25, 2643–2652 (2008).
44. Mathew, E. et al. Differential interactions of ﬂuorescent agonists and
antagonists with the yeast g protein coupled receptor Ste2p. J. Mol. Biol. 409,
513–528 (2011).
45. Son, C. D., Sargsyan, H., Naider, F. & Becker, J. M. Identiﬁcation of ligand
binding regions of the Saccharomyces cerevisiae a-factor pheromone receptor
by photoafﬁnity cross-linking. Biochemistry 43, 13193–13203 (2004).
46. Babu, M. M., Kriwacki, R. W. & Pappu, R. V. Versatility from protein disorder.
Science 337, 1460–1461 (2012).
47. Prilusky, J. et al. FoldIndex((c)): a simple tool to predict whether a given
protein sequence is intrinsically unfolded. Bioinformatics 21, 3435–3438 (2005).
48. Krogh, A., Larsson, B., von Heijne, G. & Sonnhammer, E. L. Predicting
transmembrane protein topology with a hidden Markov model: application to
complete genomes. J. Mol. Biol. 305, 567–580 (2001).
49. Reneke, J. E., Blumer, K. J., Courchesne, W. E. & Thorner, J. The carboxy-
terminal segment of the yeast alpha-factor receptor is a regulatory domain. Cell
55, 221–234 (1988).
50. Alvaro, C. G. et al. Speciﬁc alpha-arrestins negatively regulate saccharomyces
cerevisiae pheromone response by down-modulating the G-protein-coupled
receptor Ste2. Mol. Cell. Biol. 34, 2660–2681 (2014).
51. Nakamura, Y., Takemoto, N., Ishii, J. & Kondo, A. Simultaneous method for
analyzing dimerization and signaling of G-protein-coupled receptor in yeast by
dual-color reporter system. Biotechnol. Bioeng. 111, 586–596 (2014).
52. Hao, N., Yildirim, N., Wang, Y. Q., Elston, T. C. & Dohlman, H. G. Regulators
of G protein signaling and transient activation of signaling—experimental and
computational analysis reveals negative and positive feedback controls on G
protein activity. J. Biol. Chem. 278, 46506–46515 (2003).
53. Konopka, J. B., Jenness, D. D. & Hartwell, L. H. The C-terminus of the
S-cerevisiae alpha-pheromone receptor mediates an adaptive response to
pheromone. Cell 54, 609–620 (1988).
54. Shah, A. & Marsh, L. Role of Sst2 in modulating G protein-coupled receptor
signaling. Biochem. Biophys. Res. Commun. 226, 242–246 (1996).
55. Wiley, H. S. & Cunningham, D. D. A steady-state model for analyzing the
cellular-binding, internalization and degradation of polypeptide ligands. Cell
25, 433–440 (1981).
56. Dixit, G., Kelley, J. B., Houser, J. R., Elston, T. C. & Dohlman, H. G. Cellular
noise suppression by the regulator of G protein signaling Sst2. Mol. Cell 55,
85–96 (2014).
57. Morell, M., Espargaro, A., Aviles, F. X. & Ventura, S. Study and selection of
in vivo protein interactions by coupling bimolecular ﬂuorescence
complementation and ﬂow cytometry. Nat. Protoc. 3, 22–33 (2008).
58. Nagai, T., Ibata, K., Park, E. S., Kubota, M., Mikoshiba, K. & Miyawaki, A.
A variant of yellow ﬂuorescent protein with fast and efﬁcient maturation for
cell-biological applications. Nat. Biotechnol. 20, 87–90 (2002).
59. Vallier, L. G., Segall, J. E. & Snyder, M. The alpha-factor receptor C-terminus is
important for mating projection formation and orientation in Saccharomyces
cerevisiae. Cell Motil. Cytoskeleton 53, 251–266 (2002).
60. Rogers David, W., Denton Jai, A., McConnell, E. & Greig, D. Experimental
evolution of species recognition. Curr. Biol. 25, 1753–1758 (2015).
61. Kelley, J. B., Dixit, G., Sheetz, J. B., Venkatapurapu, S. P., Elston, T. C. &
Dohlman, H. G. RGS proteins and septins cooperate to promote chemotropism
by regulating polar cap mobility. Curr. Biol. 25, 275–285 (2015).
62. Kim, H., Lee, B. K., Naider, F. & Becker, J. M. Identiﬁcation of Speciﬁc
transmembrane residues and ligand-induced interface changes involved in
homo-dimer formation of a yeast G protein-coupled receptor. Biochemistry 48,
10976–10987 (2009).
63. Marcet-Houben, M. & Gabaldon, T. Beyond the Whole-Genome Duplication:
Phylogenetic Evidence for an Ancient Interspecies Hybridization in the Baker’s
Yeast Lineage. Plos Biol 13, e1002220 (2015).
64. Flock, T. et al. Universal allosteric mechanism for G alpha activation by GPCRs.
Nature 524, 173–179 (2015).
65. Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F. &
Babu, M. M. Molecular signatures of G-protein-coupled receptors. Nature 494,
185–194 (2013).
66. Bockaert, J., Marin, P., Dumuis, A. & Fagni, L. The ’magic tail’ of G
protein-coupled receptors: an anchorage for functional protein networks. Febs
Lett 546, 65–72 (2003).
67. Markovic, D. & Challiss, R. A. J. Alternative splicing of G protein-coupled
receptors: physiology and pathophysiology. Cell Mol. Life Sci. 66, 3337–3352
(2009).
68. Kilpartick, G. J., Dautzenberg, F. M., Martin, G. R. & Eglen, R. M. 7TM
receptors: the splicing on the cake. Trends Pharmacol. Sci. 20, 294–301 (1999).
69. Ding, F. X., Lee, B. K., Hauser, M., Davenport, L., Becker, J. M. & Naider, F.
Probing the binding domain of the Saccharomyces cerevisiae alpha-mating
factor receptor with ﬂuorescent ligands. Biochemistry 40, 1102–1108 (2001).
70. Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs. Nucleic Acids Res. 25, 3389–3402 (1997).
Acknowledgements
We would like to thank Dan S. Tawﬁk, Christian A. Landry and members of the
University of Toronto’s Department of Cells and Systems Biology for critical reading of
the manuscript. This work was funded by an NSERC (National Science and Engineering
Research Council, Canada) Discovery Grant 418467-2012 (S.G.P), a CFI-ORF (S.G.P.),
an Early Research Award from the Province of Ontario (S.G.P.), a Boehringer-Ingelheim
Young Researcher Award (S.G.P.), an NSERC Canadian Graduate Scholarship (R.B.D.),
an NSERC Michael Smith Foreign Study Supplement (R.B.D.), an NSERC Discovery
Grant (B.C.), the NBI Center for Models of Life (A.T.) and the Danish National Research
Foundation (A.T.).
Author contributions
R.B.D.R and S.G.P designed study; R.B.D.R. performed experiments and simulations;
A.T. provided guidance in simulations; R.B.D.R., A.T., B.C. and S.G.P. discussed results.
R.B.D.R. and S.G.P. wrote the manuscript with input and commentaries from all authors.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Di Roberto, R.B. et al. Evolution of a G protein-coupled
receptor response by mutations in regulatory network interactions. Nat. Commun.
7:12344 doi: 10.1038/ncomms12344 (2016).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
r The Author(s) 2016
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12344 ARTICLE
NATURE COMMUNICATIONS | 7:12344 | DOI: 10.1038/ncomms12344 | www.nature.com/naturecommunications 11
